134 related articles for article (PubMed ID: 10321577)
21. Design and SAR study of a novel class of nucleotide analogues as potent anti-HCMV agents.
Nguyen-Ba N; Chan L; Quimpère M; Turcotte N; Lee N; Mitchell H; Bédard J
Nucleosides Nucleotides; 1999; 18(4-5):821-7. PubMed ID: 10432685
[TBL] [Abstract][Full Text] [Related]
22. Antiviral and immunomodulatory activity of the metal chelator ethylenediaminedisuccinic acid against cytomegalovirus in vitro and in vivo.
Vogel JU; Michaelis M; Neyts J; Blaheta RA; Snoeck R; Andrei G; De Clercq E; Rabenau HF; Kreuter J; Cinatl J; Doerr HW
Antiviral Res; 2002 Jul; 55(1):179-88. PubMed ID: 12076762
[TBL] [Abstract][Full Text] [Related]
23. Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agents.
Neyts J; Snoeck R; Schols D; Himpens B; De Clercq E
J Virol Methods; 1991 Nov; 35(1):27-38. PubMed ID: 1666112
[TBL] [Abstract][Full Text] [Related]
24. Progress in understanding cytomegalovirus drug resistance.
Emery VC
J Clin Virol; 2001 Jun; 21(3):223-8. PubMed ID: 11397658
[TBL] [Abstract][Full Text] [Related]
25. Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections.
Kern ER; Rybak RJ; Hartline CB; Bidanset DJ
Antivir Chem Chemother; 2001; 12 Suppl 1():149-56. PubMed ID: 11594682
[TBL] [Abstract][Full Text] [Related]
26. Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro.
Beadle JR; Hartline C; Aldern KA; Rodriguez N; Harden E; Kern ER; Hostetler KY
Antimicrob Agents Chemother; 2002 Aug; 46(8):2381-6. PubMed ID: 12121908
[TBL] [Abstract][Full Text] [Related]
27. Value of animal models to evaluate agents with potential activity against human cytomegalovirus.
Kern ER
Transplant Proc; 1991 Jun; 23(3 Suppl 3):152-5, discussion 155. PubMed ID: 1648821
[No Abstract] [Full Text] [Related]
28. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.
Cihlar T; Fuller MD; Cherrington JM
J Virol; 1998 Jul; 72(7):5927-36. PubMed ID: 9621055
[TBL] [Abstract][Full Text] [Related]
29. Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
Snoeck R; Andrei G; De Clercq E
Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):574-9. PubMed ID: 8874075
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of the anti-human cytomegalovirus activities and toxicities of a tetrahydrofuran phosphonate analogue of guanosine and cidofovir.
Bedard J; May S; Lis M; Tryphonas L; Drach J; Huffman J; Sidwell R; Chan L; Bowlin T; Rando R
Antimicrob Agents Chemother; 1999 Mar; 43(3):557-67. PubMed ID: 10049267
[TBL] [Abstract][Full Text] [Related]
31. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
Takahashi K
Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
[TBL] [Abstract][Full Text] [Related]
32. Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method.
Kodama E; Shigeta S; Suzuki T; De Clercq E
Antiviral Res; 1996 Jul; 31(3):159-64. PubMed ID: 8811200
[TBL] [Abstract][Full Text] [Related]
33. Susceptibility of porcine cytomegalovirus to antiviral drugs.
Fryer JF; Griffiths PD; Emery VC; Clark DA
J Antimicrob Chemother; 2004 Jun; 53(6):975-80. PubMed ID: 15117919
[TBL] [Abstract][Full Text] [Related]
34. In vitro effects of antiviral agents on human keratocytes.
Moreira LB; Oliveira C; Seitz B; LaBree L; McDonnell PJ
Cornea; 2001 Jan; 20(1):69-72. PubMed ID: 11189008
[TBL] [Abstract][Full Text] [Related]
35. A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs.
Yoshida M; Yamada M; Chatterjee S; Lakeman F; Nii S; Whitley RJ
J Virol Methods; 1996 Apr; 58(1-2):137-43. PubMed ID: 8783159
[TBL] [Abstract][Full Text] [Related]
36. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes.
Smith IL; Cherrington JM; Jiles RE; Fuller MD; Freeman WR; Spector SA
J Infect Dis; 1997 Jul; 176(1):69-77. PubMed ID: 9207351
[TBL] [Abstract][Full Text] [Related]
37. Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine.
Stals FS; Zeytinoglu A; Havenith M; de Clercq E; Bruggeman CA
Antimicrob Agents Chemother; 1993 Feb; 37(2):218-23. PubMed ID: 8383939
[TBL] [Abstract][Full Text] [Related]
38. Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity.
Herget T; Freitag M; Morbitzer M; Kupfer R; Stamminger T; Marschall M
Antimicrob Agents Chemother; 2004 Nov; 48(11):4154-62. PubMed ID: 15504835
[TBL] [Abstract][Full Text] [Related]
39. Metabolism of ganciclovir and cidofovir in cells infected with drug-resistant and wild-type strains of murine cytomegalovirus.
Okleberry KM; Warren RP; Smee DF
Antiviral Res; 1997 Jul; 35(2):83-90. PubMed ID: 9217245
[TBL] [Abstract][Full Text] [Related]
40. In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome.
Cherrington JM; Fuller MD; Lamy PD; Miner R; Lalezari JP; Nuessle S; Drew WL
J Infect Dis; 1998 Dec; 178(6):1821-5. PubMed ID: 9815243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]